Cargando…

Finding the Optimal Regulatory Systems to Facilitate the Development of Novel and Advanced Therapeutics

Detalles Bibliográficos
Autor principal:	Sanada, Shoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2018
Materias:	Statement / Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925127/ https://www.ncbi.nlm.nih.gov/pubmed/33693112 http://dx.doi.org/10.1253/circrep.CR-18-0019

Ejemplares similares

Joint Declaration on COVID-19 by the Japan Stroke and Japanese Circulation Societies
por: Kishi, Takuya, et al.
Publicado: (2020)

Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention
por: Nishizaki, Yuji, et al.
Publicado: (2020)

A Novel Disease Entity in Search of Its Own Identity　― Takotsubo Syndrome. Is It Really “Cardiomyopathy”? ―
por: Doi, Yoshinori L., et al.
Publicado: (2020)

Optimizing integrated imaging service delivery by tier in low-resource health systems
por: DeStigter, Kristen, et al.
Publicado: (2021)

Current Trends in Medical Economics in the Circulatory Field　― Socioeconomics Background and Research Issue ―
por: Takura, Tomoyuki
Publicado: (2019)

Cardiac Telerehabilitation　― A Solution for Cardiovascular Care in Japan ―
por: Kaihara, Toshiki, et al.
Publicado: (2021)

Proposal of novel staging system CNM (Crohn’s primary site, nodes, mesentery) to predict postoperative recurrence of Crohn’s disease
por: Rao, Guduru Venkat, et al.
Publicado: (2023)

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
por: Kobayashi, Taku, et al.
Publicado: (2018)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

IT development in radiology - an ESR update on the Digital Imaging Adoption Model (DIAM)
Publicado: (2019)

Statement of the Italian Association of Medical Physics (AIFM) task group on radiation dose monitoring systems
por: Ria, Francesco, et al.
Publicado: (2022)

Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders
por: Mulberg, Andrew E., et al.
Publicado: (2019)

How to START? Four pillars to optimally begin your orphan drug development
por: Jonker, Anneliene Hechtelt, et al.
Publicado: (2023)

Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
por: Davis, Karen D., et al.
Publicado: (2020)

The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks
por: Evangelista, Teresinha, et al.
Publicado: (2016)

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development
por: Heslop, Emma, et al.
Publicado: (2015)

ESR paper on the proper use of mobile devices in radiology
Publicado: (2018)

Summary of the proceedings of the International Forum 2017: “Position of interventional radiology within radiology”
Publicado: (2018)

ESR paper on structured reporting in radiology
Publicado: (2018)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
Publicado: (2018)

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
por: Danese, Silvio, et al.
Publicado: (2018)

The ESR Audit Tool (Esperanto): genesis, contents and pilot
Publicado: (2018)

Radiology trainees forum survey report on workplace satisfaction, ESR education, mobility and stress level
Publicado: (2018)

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 7: suitability of taxonomic units notified to EFSA until September 2017
por: Ricci, Antonia, et al.
Publicado: (2018)

Statement on the impact of the harmonised classification on the conclusion on the peer review of the pesticide risk assessment of the active substance flutianil
Publicado: (2018)

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 8: suitability of taxonomic units notified to EFSA until March 2018
por: Ricci, Antonia, et al.
Publicado: (2018)

Annual post‐market environmental monitoring report on the cultivation of genetically modified maize MON 810 in 2016
por: Álvarez, Fernando, et al.
Publicado: (2018)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Effect on public health of a possible increase of the maximum level for ‘aflatoxin total’ from 4 to 10 μg/kg in peanuts and processed products thereof, intended for direct human consumption or use as an ingredient in foodstuffs
por: Knutsen, Helle Katrine, et al.
Publicado: (2018)

Genotoxicity assessment of chemical mixtures
por: More, Simon, et al.
Publicado: (2018)

The professional and organizational future of imaging
Publicado: (2010)

Core curriculum for medical physicists in radiology. Recommendations from an EFOMP/ESR working group
por: Geleijns, Jacob, et al.
Publicado: (2012)

Editorial on the revised European Training Charter for Clinical Radiology
Publicado: (2012)

Mammography: EUSOBI recommendations for women’s information
por: Sardanelli, Francesco, et al.
Publicado: (2011)

Radiology and primary care in Europe
Publicado: (2010)

Clinical audit—ESR perspective
Publicado: (2010)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_92ci4btidsps5is8vfleembsqg